Skip to content
Research Article Open access CC BY 3.0

In Vivo Antitumor Activity of Metal Silver and Silver Nanoparticles in the L5178Y-R Murine Lymphoma Model

José H. Lara-González, Ricardo Gomez-Flores, Patricia Tamez-Guerra, Enriqueta Monreal-Cuevas, Reyes Tamez-Guerra, Cristina Rodríguez-Padilla

Journal of Advances in Medicine and Medical Research · pp. 1308–1316 · Published 12 Apr 2013

10.9734/BJMMR/2013/3108

Abstract

Aims: To evaluate the antitumor potential of metal silver and polyvinilpyrrolidone nanoparticle-encapsulated silver on L5178Y-R murine lymphoma cell growth and survival of tumor-bearing mice. Study Design: In vitro and in vivo (pre-clinical) study. Place and Duration of Study: Universidad Autónoma de Nuevo León, Facultad de Ciencias Biológicas, Departamento de Microbiología e Inmunología, San Nicolás de los Garza, N.L., México, from January 2009 to December 2011. Methodology: Concentration-response cell viability assay was performed in vitro and mice survival studies were done using a L5178Y-R tumor-bearing mouse model. The PROBIT regression analysis was performed to determine the in vitro LC50. In vivo survival distributions were calculated by Kaplan-Meier and Cutler-Ederer analysis, and survival curves comparisons and hypothesis testing was done using the log-rank method. Results: Metal silver induced up to 100% L5178Y-R cells cytotoxicity, with an LC50 of 1.8 X 10-8 M, whereas silver nanoparticles caused up to 78% cytotoxicity, with an LC50 of 14.4 X 10-8 M. In addition, Intramuscular administration of metal silver and silver nanoparticles administered at the time of tumor injection significantly (P = .05) increased mice survival, where 70% and 60% of mice survived at day 35 respectively, as compared with such treatments administered 7 days after tumor induction (55% and 25% survival respectively); vincristine treatment caused 50% mice survival and tumor-bearing control mice had 20% survival. These results open further approaches on treating several types of cancer using free and nanoparticle-encapsulated silver-based therapies.

Silver silver nanoparticles lymphoma antitumor activity preclinical mouse

Cited by 16

Role of inorganic nanoparticle degradation in cancer therapy

Christy Maksoudian, Neshat Saffarzadeh, Evelien Hesemans · Nanoscale Advances · 2020

The effect of silver nanoparticles (AgNPs) on proliferation and apoptosis of in ovo cultured glioblastoma multiforme (GBM) cells

Kaja Urbańska, Beata Pająk, Arkadiusz Orzechowski · Nanoscale Research Letters · 2015

Strategic role of selected noble metal nanoparticles in medicine

Mahendra Rai, Avinash P. Ingle, Sonal Birla · Critical Reviews in Microbiology · 2015

Survival Analysis

Lawrence M. Friedman, Curt D. Furberg, David L. DeMets · Fundamentals of Clinical Trials · 2015

Monitoring and tracking metallic nanobiomaterials in vivo

D. Pissuwan · Monitoring and Evaluation of Biomaterials and their Performance In Vivo · 2017

Applications of Gold and Silver Nanoparticles in Theranostics

R. Sakthi Devi, Agnishwar Girigoswami, M. Siddharth · Applied Biochemistry and Biotechnology · 2022

Biosynthesis of Silver Nanoparticles by Marine Invertebrate (Polychaete) and Assessment of Its Efficacy against Human Pathogens

Reena Singh, Sunil Kumar Sahu, Muthusamy Thangaraj · Journal of Nanoparticles · 2014

Article metrics

Real usage data collected on this platform.

1

Page views

0

PDF downloads

0

Outbound clicks

16

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.